Sort by:
Results Per Page:
Highly potent EGFR-kinase inhibitor
Orally active, selective EGFR inhibitor
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
Potent, reversible EGFR tyrosine kinase inhibitor
EGFR kinase inhibitor. Also estrogen and PPARγ ligand
Negative control for PP 2 (Cat. No. 1407)
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor
Selective ErbB2 inhibitor
Potent dual EGFR/ErbB2 inhibitor; orally active
Potent ErbB receptor family inhibitor
Potent ErbB receptor family inhibitor
Potent and selective ErbB2 inhibitor
Potent EGFR and VEGFR inhibitor
Potent EGFR kinase inhibitor
Potent irreversible pan ErbB inhibitor
Potent mutant-selective EGFR inhibitor
Potent dual specificity EGFR/HER2 inhibitor; active in vivo
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors
Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor
Inhibitor of EGFR mutants
Potent VEGFR-2 inhibitor, also inhibits EGFR and RET oncoproteins activity
Potent and selective ErbB2 inhibitor